LibiGel is in development for the treatment of female sexual dysfunction (FSD) specifically hypoactive sexual desire disorder (HSDD) in menopausal women for which there is no FDA-approved product. Data are being ...

guest published in:10-29   reply:0   view:58    last updated:10-29 20:30( guest )

InvestorIdeas.com a global investor research portal for independent investors features an investor FAQ and Fact Sheet for specialty pharmaceutical company BioSante Pharmaceuticals Inc: (NASDAQ: BPAX). Date Released: 08/26/2011 Investor FAQs and Facts for BioSante Pharmaceuticals Inc: (NASDAQ: ...

guest published in:10-07   reply:0   view:18    last updated:10-07 13:29( guest )

Northern WI 8/23/2011 (PennyPayDay) -- www.InvestorIdeas.com a global investor research portal for independent investors features an investor FAQ and Fact Sheet for specialty pharmaceutical company BioSante Pharmaceuticals Inc: (NASDAQ: BPAX). BioSantes (NASDAQ: BPAX) stock has built a sig ...

guest published in:09-13   reply:0   view:24    last updated:09-13 06:29( guest )

Investor FAQs and Facts for BioSante Pharmaceuticals Inc: (NASDAQ: BPAX) POINT ROBERTS August 24 2001 www.InvestorIdeas.com a global investor research portal for independent investors features an investor FAQ and Fact Sheet for specialty pharmaceutical company BioSante Pharmaceuticals Inc ...

guest published in:09-09   reply:0   view:31    last updated:09-09 04:30( guest )

Point Roberts WA LINCOLNSHIRE Ill July 12 2011 Investorideas.com a leader in sector stock research for independent investors issues a trading alert for specialty biotech/pharma stock BioSante Pharmaceuticals Inc. (NASDAQ: BPAX) for July 11 th. The stock traded as high as $3.90 on over 9 Mil ...

guest published in:07-21   reply:0   view:28    last updated:07-21 23:29( guest )

author:admin    comment:0   view:13   userful 1

BEDFORD Mass. Dec. 1 2011 /PRNewswire/ -- Hologic Inc. (NASDAQ: HOLX) today announced that Glenn Muir Executive Vice President and Chief Financial Officer will be presenting at the Nasdaq OMX 27th Investor Program in London on Tuesday December 6 2011 at 11:15am...